Panion & BF Biotech Inc (1760) — Cash Flow Quality Index
Panion & BF Biotech Inc (1760) has a Cash Flow Quality Index of 0.70x as of September 2025. Operating cash flow of NT$73.31 Million is below net income of NT$104.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 1760 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Panion & BF Biotech Inc Cash Flow Quality Index (2009–2024)
Historical Cash Flow Quality Index for Panion & BF Biotech Inc across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Panion & BF Biotech Inc operating cash flow efficiency.
Annual Cash Flow Quality Index for Panion & BF Biotech Inc (2009–2024)
Year-by-year earnings quality comparison for Panion & BF Biotech Inc.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.62x | NT$351.19 Million | NT$217.44 Million | ▼ -29.7% |
| 2023 | 2.30x | NT$177.42 Million | NT$77.22 Million | ▼ -14.5% |
| 2022 | 2.69x | NT$489.87 Million | NT$182.34 Million | ▲ +22.3% |
| 2021 | 2.20x | NT$401.23 Million | NT$182.65 Million | ▲ +1449.3% |
| 2020 | -0.16x | NT$-14.55 Million | NT$89.41 Million | ▼ -140.5% |
| 2019 | 0.40x | NT$90.98 Million | NT$226.29 Million | ▲ +25.0% |
| 2018 | 0.32x | NT$78.58 Million | NT$244.38 Million | ▼ -59.6% |
| 2017 | 0.80x | NT$113.97 Million | NT$143.14 Million | ▼ -41.8% |
| 2016 | 1.37x | NT$177.22 Million | NT$129.42 Million | ▲ +172.9% |
| 2015 | 0.50x | NT$58.30 Million | NT$116.19 Million | ▼ -50.8% |
| 2014 | 1.02x | NT$76.11 Million | NT$74.57 Million | ▼ -72.5% |
| 2013 | 3.72x | NT$86.22 Million | NT$23.20 Million | ▼ -94.0% |
| 2009 | 62.08x | NT$76.98 Million | NT$1.24 Million | — |